1. Market Research
Customer Support

Talk to Ahmad

+1 718 618 4302

Top Countries

Publishers

  • All
    • Visiongain
10 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Cancer Immunotherapy Market Forecast 2019-2029

  • $ 4374
  • January 2019
  • 194 pages

Global Cancer Immunotherapy Market for Other Cancer types (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma): ($m, AGR%, CAGR%) 2018-2029 Table ##. ##.

  • Cancer Immunotherapy
  • Lymphoma
  • Therapy
  • World
  • Market Size

Global Cancer Immunotherapy Market to 2027

  • $ 4468
  • December 2017
  • 165 pages

Global Cancer Immunotherapy Market for Other Cancer types (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma), ($m, AGR%, CAGR%) 2016-2027 Table ##. ##.

  • Cancer Immunotherapy
  • Lymphoma
  • Therapy
  • World
  • Market Size

GLOBAL STEM CELL TECHNOLOGIES AND APPLICATIONS MARKET 2018-2028

  • $ 4468
  • March 2018
  • 284 pages

Estimated New Cases of Leukemia, Lymphoma and Myeloma in 2017 Figure ##. ##.

  • Cell Therapy
  • Lymphoma
  • Medical Biotechnology
  • World

Global Next-Generation Antibody Therapies Market Forecast 2018-2028

  • $ 4468
  • September 2018
  • 217 pages

Lymphoma and Leukaemia ##.

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Market Size

Biologics Market Trends and Forecasts 2018-2028

  • $ 4374
  • November 2018
  • 303 pages

Lymphoma and Being Investigated for Other Indications ##. ##. ## Avastin: Growing under CER, Through New Indications ##. ##. ##. ## Controversy over Off-Label Avastin use: Roche is Backed up by Incidents in India, and Opinion of EFPIA ##. ##. ##. ## Biosimilar Bevacizumab: Late Patent Expiry is a Blessing for

  • Biopharmaceutical
  • Lymphoma
  • Medical Biotechnology
  • World

Biologics Market Trends and Forecasts to 2027

  • $ 4468
  • November 2017
  • 300 pages

Lymphoma and Being Investigated for Other Indications ##. ##. ## Avastin: Growing under CER, Through New Indications ##. ##. ##. ## Controversy over Off-Label Avastin use: Roche is Backed up by Incidents in India, and Opinion of EFPIA ##. ##. ##. ## Biosimilar Bevacizumab: Late Patent Expiry is a Blessing for

  • Biopharmaceutical
  • Lymphoma
  • Medical Biotechnology
  • World

Next-Generation Antibody Therapies Market Forecast 2016-2026: Explore Developments and Sales Potentials for ADCs, Engineered Antibodies, ALPs, Bispecific and Biosimilar Agents

  • $ 4468
  • April 2016
  • 241 pages

Lymphoma and Leukaemia ##.

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Market Size

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024

  • $ 4468
  • June 2014
  • 189 pages

Lymphoma Kinase (ALK) Inhibitors In Development ##. ##. ## Alectinib – Roche ##. ##. ##. ## Alectinib Forecast, 2014-2024 ##. ##. ## Ceritinib (LDK##) - Novartis ##. ##. ##. ## Ceritinib Forecast, 2014-2024 ##. ##. ## AP## - ARIAD ##. ## Bruton’s Tyrosine Kinase and PI##K Inhibitors in Development ##. ##. ## Idelalisib – Gi

  • Lymphoma
  • Oncology
  • Targeted Therapy
  • Therapy
  • Market Size

Anti-Cancer Drugs Industry and Market: Therapies, R&D and Forecasts 2014-2024

  • $ 4468
  • August 2014
  • 275 pages

Anti-Cancer Drugs Industry and Market: Therapies, R& D and Forecasts 2014-2024 ##.

  • Lymphoma
  • Oncology
  • Therapy
  • World
  • Market Size

Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024

  • $ 4468
  • June 2014
  • 254 pages

Epigenetic R& D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024 ##.

  • Lymphoma
  • Therapy
  • World
  • Market Size


View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on